Female Fertility Rapid Tests - Global Medical Devices Pipeline Assessment Report, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides an overview of Female Fertility Rapid Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.

The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products.

Scope

  • Extensive coverage of the Female Fertility Rapid Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Female Fertility Rapid Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Female Fertility Rapid Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered

1 Table of Contents

2 Introduction

2.1 Female Fertility Rapid Tests Overview

3 Products under Development

3.1 Female Fertility Rapid Tests - Pipeline Products by Stage of Development

3.2 Female Fertility Rapid Tests - Pipeline Products by Segment

3.3 Female Fertility Rapid Tests - Pipeline Products by Territory

3.4 Female Fertility Rapid Tests - Pipeline Products by Regulatory Path

3.5 Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

4 Female Fertility Rapid Tests - Pipeline Products under Development by Companies

4.1 Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development

4.2 Female Fertility Rapid Tests - Pipeline Products by Stage of Development

5 Female Fertility Rapid Tests Companies and Product Overview

5.1 BBB Technologies Inc Company Overview

5.2 Bio-AMD Inc.

5.3 ET Healthcare Inc.

5.4 MFB Fertility Inc.

5.5 NG Biotech

5.6 OPKO Health Inc.

5.7 Pop Test LLC

5.8 PragmaDX Inc.

5.9 Quidel Corp.

6 Female Fertility Rapid Tests - Recent Developments

6.1 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results

6.2 May 28, 2019: True Diagnostics receives FDA 510(k) clearance to market VeriClear Digital Test Device for early result pregnancy

6.3 May 14, 2019: Sekisui Diagnostics invests $1.9 million in Microbial Biopharma CDMO business

6.4 May 08, 2019: Quidel reports first quarter 2019 financial results

6.5 Apr 01, 2019: Mologic expands US and UK operations

6.6 Feb 27, 2019: Sekisui Diagnostics expanding again and adding more jobs

6.7 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results

6.8 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018

6.9 Nov 06, 2018: Quidel reports third quarter 2018 financial results

List of Tables

Table 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development

Table 2: Female Fertility Rapid Tests - Pipeline Products by Segment

Table 3: Female Fertility Rapid Tests - Pipeline Products by Territory

Table 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path

Table 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

Table 6: Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development

Table 7: Female Fertility Rapid Tests - Pipeline Products by Stage of Development

Table 8: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 19: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 24: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 35: MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 38: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview

Table 47: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 50: Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 53: PragmaDX Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 56: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview

Table 59: Glossary

List of Figures

Figure 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development

Figure 2: Female Fertility Rapid Tests - Pipeline Products by Segment

Figure 3: Female Fertility Rapid Tests - Pipeline Products by Territory

Figure 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path

Figure 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

For more information about this report visit https://www.researchandmarkets.com/r/sx5ha3

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900